APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling.
Saved in:
| Title: | APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling. |
|---|---|
| Authors: | Sturdivant MS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Truong AS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Zhou M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Toomer ED; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Beckabir W; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Raupp J; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Manocha U; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Zambrano IA; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Tan HJ; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Bjurlin MA; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Smith AB; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Rose TL; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wobker SE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gessner KH; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Damrauer JS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jeffrey_damrauer@med.unc.edu.; Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jeffrey_damrauer@med.unc.edu., Kim WY; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.; Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu.; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wykim@med.unc.edu. |
| Source: | Nature communications [Nat Commun] 2025 Dec 14; Vol. 17 (1), pp. 334. Date of Electronic Publication: 2025 Dec 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
